levothyroxine sodium
Generic: levothyroxine sodium anhydrous
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
levothyroxine sodium
Generic Name
levothyroxine sodium anhydrous
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
levothyroxine sodium anhydrous 500 ug/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-648
Product ID
63323-648_1da8e5bc-aeb7-4168-a8c3-e1d9a9d167ea
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA202231
Listing Expiration
2026-12-31
Marketing Start
2011-06-24
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323648
Hyphenated Format
63323-648
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levothyroxine sodium (source: ndc)
Generic Name
levothyroxine sodium anhydrous (source: ndc)
Application Number
NDA202231 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 ug/5mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-648-10) / 5 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (2)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "1da8e5bc-aeb7-4168-a8c3-e1d9a9d167ea", "openfda": {"upc": ["0363323648107", "0363323649074", "0363323647100"], "unii": ["054I36CPMN"], "rxcui": ["966219", "1115267", "1115269"], "spl_set_id": ["ce990712-49c1-4f66-9ee4-c770e8ec394c"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-648-10) / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-648-10", "marketing_start_date": "20110624"}], "brand_name": "Levothyroxine Sodium", "product_id": "63323-648_1da8e5bc-aeb7-4168-a8c3-e1d9a9d167ea", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Thyroxine [CS]", "l-Thyroxine [EPC]"], "product_ndc": "63323-648", "generic_name": "LEVOTHYROXINE SODIUM ANHYDROUS", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levothyroxine Sodium", "active_ingredients": [{"name": "LEVOTHYROXINE SODIUM ANHYDROUS", "strength": "500 ug/5mL"}], "application_number": "NDA202231", "marketing_category": "NDA", "marketing_start_date": "20110624", "listing_expiration_date": "20261231"}